Followers

November 24, 2023

GLP1R-targeting drugs will continue to see demand due to pleiotropic benefits: Experts

Despite the unavailability of Ozempic and Wegovy in India, the queries on the use and availability of the diabetes treatment drug continue to pour in on a daily basis for medical practitioners.


No comments:

Post a Comment